secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001193125-24-231158
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra extends Hercules loan maturity to April 2026; interest rate floor 11.10%
--------------------------------------------------------------------------------

- Fourth Amendment extends interest-only period to April 1, 2026 and maturity to same date.
- Outstanding $15M term loan; interest rate increased to Prime + 3.10% (floor 11.10%).
- New $300K end-of-term charge payable at maturity or prepayment.
- No other changes to loan covenants or collateral; reaffirms existing security interests.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312524231158/0001193125-24-231158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312524231158/d875044d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-231158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer